Fondazione Policlinico Universitario Gemelli-IRCCS

Roma 00168

1 studies enrolling now · 2 studies all time

What they study most

Biliary Tract Cancer, Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Studies at this site

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations — Stopped early